biostudies-literatureUnknown6(4)Ngo QM<h4>Background</h4>The COVID-19 pandemic has profoundly transformed substance use disorder (SUD) treatment in the United States, with many web-based treatment services being used for this purpose. However, little is known about the long-term treatment effectiveness of SUD interventions delivered through digital technologies compared with in-person treatment, and even less is known about how patients, clinicians, and clinical characteristics may predict treatment outcomes.<h4>Objective</h4>This study aims to analyze baseline differences in patient demographics and clinical characteristics across traditional and telehealth settings in a sample of participants (N=3642) who received intensive outpatient program (IOP) substance use treatment from January 2020 to March 2021.<h4>Methods</h4>The virtual IOP (VIOP) study is a prospective longitudinal cohort design that follows adult (aged ≥18 years) patients who were discharged from IOP care for alcohol and substance use-related treatment at a large national SUD treatment provider between January 2020 and March 2021. Data were collected at baseline and up to 1 year after discharge from both in-person and VIOP services through phone- and web-based surveys to assess recent substance use and general functioning across several domains.<h4>Results</h4>Initial baseline descriptive data were collected on patient demographics and clinical inventories. No differences in IOP setting were detected by race (χ²₂=0.1; P=.96), ethnicity (χ²₂=0.8; P=.66), employment status (χ²₂=2.5; P=.29), education level (χ²₄=7.9; P=.10), or whether participants presented with multiple SUDs (χ²₈=11.4; P=.18). Significant differences emerged for biological sex (χ²₂=8.5; P=.05), age (χ²₆=26.8; P<.001), marital status (χ²₄=20.5; P<.001), length of stay (F_2,3639=148.67; P<.001), and discharge against staff advice (χ²₂=10.6; P<.01). More differences emerged by developmental stage, with emerging adults more likely to be women (χ²₃=40.5; P<.001), non-White (χ²₃=15.8; P<.001), have multiple SUDs (χ²₃=453.6; P<.001), have longer lengths of stay (F_3,3638=13.51; P<.001), and more likely to be discharged against staff advice (χ²₃=13.3; P<.01).<h4>Conclusions</h4>The findings aim to deepen our understanding of SUD treatment efficacy across traditional and telehealth settings and its associated correlates and predictors of patient-centered outcomes. The results of this study will inform the effective development of data-driven benchmarks and protocols for routine outcome data practices in treatment settings.JMIR formative researche34408https://www.ebi.ac.uk/biostudies/studies/S-EPMC9016509biostudies-literatureIn-Person Versus Telehealth Setting for the Delivery of Substance Use Disorder Treatment: Ecologically Valid Comparison Study.PMC9016509Sitar SWelsh JWGliske KKretman DNCooper HLFBraughton JEWaller LANgo QMfalseIn-Person Versus Telehealth Setting for the Delivery of Substance Use Disorder Treatment: Ecologically Valid Comparison Study.<h4>Background</h4>The COVID-19 pandemic has profoundly transformed substance use disorder (SUD) treatment in the United States, with many web-based treatment services being used for this purpose. However, little is known about the long-term treatment effectiveness of SUD interventions delivered through digital technologies compared with in-person treatment, and even less is known about how patients, clinicians, and clinical characteristics may predict treatment outcomes.<h4>Objective</h4>This study aims to analyze baseline differences in patient demographics and clinical characteristics across traditional and telehealth settings in a sample of participants (N=3642) who received intensive outpatient program (IOP) substance use treatment from January 2020 to March 2021.<h4>Methods</h4>The virtual IOP (VIOP) study is a prospective longitudinal cohort design that follows adult (aged ≥18 years) patients who were discharged from IOP care for alcohol and substance use-related treatment at a large national SUD treatment provider between January 2020 and March 2021. Data were collected at baseline and up to 1 year after discharge from both in-person and VIOP services through phone- and web-based surveys to assess recent substance use and general functioning across several domains.<h4>Results</h4>Initial baseline descriptive data were collected on patient demographics and clinical inventories. No differences in IOP setting were detected by race (χ²₂=0.1; P=.96), ethnicity (χ²₂=0.8; P=.66), employment status (χ²₂=2.5; P=.29), education level (χ²₄=7.9; P=.10), or whether participants presented with multiple SUDs (χ²₈=11.4; P=.18). Significant differences emerged for biological sex (χ²₂=8.5; P=.05), age (χ²₆=26.8; P<.001), marital status (χ²₄=20.5; P<.001), length of stay (F_2,3639=148.67; P<.001), and discharge against staff advice (χ²₂=10.6; P<.01). More differences emerged by developmental stage, with emerging adults more likely to be women (χ²₃=40.5; P<.001), non-White (χ²₃=15.8; P<.001), have multiple SUDs (χ²₃=453.6; P<.001), have longer lengths of stay (F_3,3638=13.51; P<.001), and more likely to be discharged against staff advice (χ²₃=13.3; P<.01).<h4>Conclusions</h4>The findings aim to deepen our understanding of SUD treatment efficacy across traditional and telehealth settings and its associated correlates and predictors of patient-centered outcomes. The results of this study will inform the effective development of data-driven benchmarks and protocols for routine outcome data practices in treatment settings.2022-01-01T00:00:00Z2022 Apr2025-04-05T11:51:40.743Z2025-02-19T04:57:48.116ZS-EPMC90165093537731810.2196/34408